Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study

• Asıl Yazarlar: Valentina Giudice (Yazar), Pasquale Pagliano (Yazar), Alessandro Vatrella (Yazar), Alfonso Masullo (Yazar), Sergio Poto (Yazar), Benedetto Maria Polverino (Yazar), Renato Gammaldi (Yazar), Angelantonio Maglio (Yazar), Carmine Sellitto (Yazar), Carolina Vitale (Yazar), Bianca Serio (Yazar), Bianca Cuffa (Yazar), Anna Borrelli (Yazar), Carmine Vecchione (Yazar), Amelia Filippelli (Yazar), Carmine Selleri (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2020-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

To date, there are no specific therapeutic strategies for treatment of COVID-19. Based on the hypothesis that complement and coagulation cascades are activated by viral infection, and might trigger an acute respiratory distress syndrome (ARDS), we report clinical outcomes of 17 consecutive cases of...